ESOPRAX cpr pell 20 mg 10 pce

7680663210157 CH-66321 A02BC05 04.99.0.

Active substances:

No images available

Details

Product number
6632101
CPT
-
Packaging group
10
Unit
Tablette(n)
Composition
esomeprazolum 20 mg ut esomeprazolum magnesicum dihydricum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, talcum, triethylis citras, hypromellosum, sacchari sphaerae corresp. saccharum max. 5.62 mg, magnesii stearas, hydroxypropylcellulosum, glyceroli monostearas 40-55, polysorbatum 80, cellulosum microcristallinum, povidonum K 30, macrogolum 6000, crospovidonum, natrii stearylis fumaras corresp. natrium 0.04 mg, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto.

Articles (1)

Esoprax 20 mg, magensaftresistente Tabletten
Magensaftresistente Tabletten
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/01/2021
Patient information leaflet
Français
01/01/2021
Patient information leaflet
Italien
01/01/2021
Professional SmPC
Allemand
01/01/2021
Professional SmPC
Français
01/01/2021

Detailed composition

Substance Quantity Type Category
esomeprazolum
20.0 MG Substance Wirkstoff (Principe actif)
esomeprazolum magnesicum dihydricum
- Substance WIZUS
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
talcum
- Substance HNIDK
triethylis citras
- Substance HNIDK
hypromellosum
- Substance HNIDK
sacchari sphaerae
- Substance HNIDK
saccharum
- Substance HBESI
magnesii stearas
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
glyceroli monostearas 40-55
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
crospovidonum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
natrium
0.04 MG Substance HBESI
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK

Authorization holder

Drossapharm AG

4051 Basel

Authorization information

Swissmedic authorization number
66321
Drug name
Esoprax, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
A02BC05
Authorization status
Z
Dispensation category
B
First authorization
12/07/2017
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Protonenpumpenblocker

Packaging details

Description (FR)
ESOPRAX cpr pell 20 mg 10 pce
Description (DE)
ESOPRAX Filmtabl 20 mg 10 Stk
Market launch
12/07/2017
Narcotic (BTM)
No

Available generics

Esomep, MUPS-Tabletten
CHF 16.25
View
Esomep, MUPS-Tabletten
CHF 30.25
View
Esomep, MUPS-Tabletten
CHF 40.75
View
Esomep, MUPS-Tabletten
CHF 51.90
View
Esomep, MUPS-Tabletten
CHF 17.10
View
Esomep, MUPS-Tabletten
CHF 31.55
View
Esomep, MUPS-Tabletten
CHF 45.95
View
Esomep, MUPS-Tabletten
CHF 59.65
View
Esomeprazol Axapharm, magensaftresistente Tabletten
CHF 15.35
View
Esomeprazol Axapharm, magensaftresistente Tabletten
CHF 28.40
View

Other packaging sizes

ESOPRAX cpr pell 20 mg 14 pce
14 TABL
View
ESOPRAX cpr pell 20 mg 30 pce
30 TABL
View
ESOPRAX cpr pell 20 mg 60 pce
60 TABL
View
ESOPRAX cpr pell 20 mg 100 pce
100 TABL
View
ESOPRAX cpr pell 40 mg 14 pce
14 TABL
View
Buy us a coffee Explore the data